We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Respiri is a medical devices business based in Australia. Respiri shares (RSH) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Respiri has a trailing 12-month revenue of around $883,392. If you're looking to buy shares, check out the steps below.
How to buy shares in Respiri
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Respiri . Find the share by name or ticker symbol: RSH. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Respiri reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Respiri . Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
US stocks

Our top pick for
Long-term investing

Our top pick for
Low-cost broker

Respiri stock price (ASX:RSH)
Use our graph to track the performance of RSH stocks over time.Respiri shares at a glance
52-week range | $0.032 - $0.1025 |
---|---|
50-day moving average | $0.0432 |
200-day moving average | $0.0545 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.011 |
Compare share trading platforms
Is it a good time to buy Respiri stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Respiri price performance over time
Historical closes compared with the last close of A$0.053
1 week (2022-06-20) | 35.90% |
---|---|
1 month (2022-05-30) | 51.43% |
3 months (2022-03-30) | -7.02% |
6 months (2021-12-30) | -19.70% |
1 year (2021-06-30) | -20.90% |
---|---|
2 years (2020-06-30) | -40.45% |
3 years (2019-06-28) | -39.77% |
5 years (2017-06-27) | 29.27% |
Respiri financials
Revenue TTM | $883,392 |
---|---|
Gross profit TTM | $122,543 |
Return on assets TTM | -49.06% |
Return on equity TTM | -93.84% |
Profit margin | 0% |
Book value | 0.007 |
Market capitalisation | $42.7 million |
TTM: trailing 12 months
Respiri share dividends
We're not expecting Respiri to pay a dividend over the next 12 months.
Have Respiri 's shares ever split?
Respiri 's shares were split on a 1:20 basis on 31 July 2012. So if you had owned 20 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Respiri shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Respiri shares which in turn could have impacted Respiri 's share price.
Respiri share price volatility
Over the last 12 months, Respiri 's shares have ranged in value from as little as $0.032 up to $0.1025. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Respiri 's is -0.0553. This would suggest that Respiri 's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Respiri has bucked the trend.
Respiri overview
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and Israel. The company develops, produces, and sells mobile health applications. Its products include Wheezo, an asthma management tool to help user understand their asthma by providing information, such as triggers, symptoms, medication usage, and other events. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
Stocks similar to Respiri
Respiri in the news
Frequently asked questions
More guides on Finder
-
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
-
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
-
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
-
How to buy Leo lithium shares
Steps to owning and managing Leo lithium shares.
-
How to buy Besra Gold (BEZ) shares
Steps to owning and managing Besra Gold shares.
Ask an Expert